Wells Fargo Company MN reduced its investment in United Therapeutics Co. by 13.4% during the fourth quarter as reported in its Form 13F filing with the SEC.
United Therapeutics Co. had its shares sold by Wells Fargo & Company MN. Read More »
United Therapeutics is a company that is seen as exciting but faces a major challenge.
StockNews.com raised United Therapeutics shares’ rating from buy to strong-buy in a report released on Thursday. Several other analysts also made upgrades and downgrades to the company’s stock.
United Therapeutics’ rating on StockNews.com has been elevated to a “Strong-Buy.” Read More »
Stay updated with the latests analysis and insights fromm etfsector.com